Adult Dosing

Tinea corporis, tinea cruris, tinea versicolor

• Apply qd x 2 wks

Tinea pedis

• Apply qd x 4 wk or apply bid x 7 days

Pediatric Dosing

Tinea corporis, tinea cruris, tinea versicolor

Child > 12 yrs

• Apply qd x 2 wks

Tinea pedis

Child > 12 yrs

• Apply qd x 4 wk or apply bid x 7 days

[Outline]

• Adult Dosing
• Pediatric Dosing

• Antifungal for treating skin infections from susceptible organisms like tinea corporis, tinea cruris, tinea pedis, tinea versicolor

• Hypersensitivity to any of the ingredients of the product

• N/A

Renal Dose Adjustment

• Renal impairment: No dose adjustments

Hepatic Dose Adjustment:

• Hepatic impairment: No dose adjustments

See Supplemental Patient Information

• Therapy should be used externally only
• Suspend therapy and institute appropriate therapy if irritation or sensitivity develops after application
• Patients who are known to be sensitive to allylamine antifungals should use therapy, since cross-reactivity may occur

Caution: Use cautiously in

• Hypersensitivity to terbinafine

Supplemental Patient Information

• Use as directed by the physician, and avoid contact with the eyes, nose, and mouth, and other mucous membranes

Pregnancy Category:B

Breastfeeding: Safety unknown. Because it is poorly absorbed after topical application, it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 8 April 2011). Manufacturer advises caution.

• LOCAL: Irritation, burning, itching, local hypersensitivity reactions, redness, stinging, erythema, contact dermatitis

• Topical antifungal agent; it inhibits the synthesis of the fungal cell wall
• Minimal systemic absorption
• Metabolized through hydroxylation
• Excreted in urine
• Half-life: 35 hrs (initial); >150 hrs (terminal)

US Trade Name(s)

• Lotrimin Ultra
• Mentax

US Availability

Lotrimin Ultra

• CRE: 1% (12 g)

Mentax

• CRE: 1% (15, 30 g)

Canadian Trade Name(s)

• N/A

Canadian Availability

• N/A

UK Trade Name(s)

• N/A

UK Availability

• N/A

Australian Trade Name(s)

• N/A

Australian Availability

• N/A

[Outline]

Antimicrobials

Dermatologic Topical Agents

Antifungals

Infectious Disease

Dermatologic Topical Agents

Antifungals

Dermatologic

Dermatologic Topical Agents

Antifungals

Pricing data from www.DrugStore.com in U.S.A.

• Mentax 1 % CREA [Tube] (MYLAN)
  30 % = $132
  90 % = $368.45
• Mentax 1 % CREA [Tube] (MYLAN)
  15 % = $70.39
  45 % = $197.97

Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.